Effects of GLP-1 receptor agonists on neurological complications of diabetes

Emerging evidence suggests that treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) could be an interesting treatment strategy to reduce neurological complications such as stroke, cognitive impairment, and peripheral neuropathy. We performed a systematic review to examine the eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Casares, Natalia, González-González, Guillermo, de la Cruz-Cosme, Carlos, Garzón-Maldonado, Francisco J, de Rojas-Leal, Carmen, Ariza, María J, Narváez, Manuel, Barbancho, Miguel Ángel, García-Arnés, Juan Antonio, Tinahones, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404567/
https://www.ncbi.nlm.nih.gov/pubmed/37231200
http://dx.doi.org/10.1007/s11154-023-09807-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404567/
https://www.ncbi.nlm.nih.gov/pubmed/37231200
http://dx.doi.org/10.1007/s11154-023-09807-3

Ejemplares similares